MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

04 Aug 2025 Evaluate
The June 2025 quarter revenue stood at Rs. 28481.70 millions, up 15.78% as compared to Rs. 24600.90 millions during the corresponding quarter last year.The Profit  for the quarter ended June 2025 of  Rs. 5591.30  millions  grew by 69.93% from Rs. 3290.40 millions.OP of the company witnessed a marginal growth to 8801.10 millions from 5642.50 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 28481.70 24600.90 15.78 28481.70 24600.90 15.78 109333.00 106456.40 2.70
Other Income 837.70 653.20 28.25 837.70 653.20 28.25 3281.20 6160.60 -46.74
PBIDT 8801.10 5642.50 55.98 8801.10 5642.50 55.98 28856.90 28401.00 1.61
Interest 600.00 511.30 17.35 600.00 511.30 17.35 2300.40 1826.00 25.98
PBDT 8201.10 5131.20 59.83 8201.10 5131.20 59.83 26556.50 26575.00 -0.07
Depreciation 700.20 668.80 4.69 700.20 668.80 4.69 2972.00 2545.80 16.74
PBT 7500.90 4462.40 68.09 7500.90 4462.40 68.09 23584.50 24029.20 -1.85
TAX 1909.60 1172.00 62.94 1909.60 1172.00 62.94 6116.60 5028.20 21.65
Deferred Tax 32.80 -24.60 -233.33 32.80 -24.60 -233.33 -157.10 -952.60 -83.51
PAT 5591.30 3290.40 69.93 5591.30 3290.40 69.93 17467.90 19001.00 -8.07
Equity 580.80 585.90 -0.87 580.80 585.90 -0.87 580.80 585.90 -0.87
PBIDTM(%) 30.90 22.94 34.73 30.90 22.94 34.73 26.39 26.68 -1.07
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..